Heat shock protein 90

Discussion Board › Forums › General Discussion › Heat shock protein 90

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • September 9, 2012 at 9:56 pm #64258
    Eli
    Spectator

    The study that Gavin linked was done in a dish.

    17-AAG is the name of the drug. Heat shock protein 90 (HSP90) is the target of the drug.

    17-AAG is also known as Tanespimycin. It was tested in a number of clinical trials:

    http://clinicaltrials.gov/ct2/results?term=tanespimycin

    None of these trials involved cholangiocarcinoma.

    This article says that Bristol-Myers (pharma company) has abandoned development of the drug:

    http://www.myelomabeacon.com/news/2010/07/22/tanespimycin-development-halted/

    September 9, 2012 at 9:06 pm #64257
    gavin
    Moderator

    Hi Anna,

    Is this what popped up on your FB page today?

    http://www.biomedsearch.com/nih/heat-shock-protein-90-inhibitor/22955701.html

    Have you tried using the search forum function at the top of the page to see what else is here on the site?

    Best wishes to you,

    Gavin

    September 9, 2012 at 8:59 pm #64256
    lainy
    Spectator

    Anna, Gavin just posted a link on this very question today.

    September 9, 2012 at 8:13 pm #7326
    pak001
    Spectator

    Anyone have any experience or knowledge of this target therapy: HSP90-
    heat shock protein 90? It popped up on my FB page and there’s not too much info that I can find on it’s significance on cholangiocarcinoma

  • Author
    Posts
Viewing 4 posts - 1 through 4 (of 4 total)
  • The forum ‘General Discussion’ is closed to new topics and replies.